|
Chugai Pharma
|
6,799.00 |
|
-243.00 |
-3.45% |
19.41% |
2025-03-31 |
|
Daiichi Sankyo
|
3,511.00 |
|
-158.00 |
-4.31% |
-24.77% |
2025-03-31 |
|
Alnylam Pharmaceuticals
|
270.26 |
|
1.80 |
0.67% |
76.26% |
2025-03-31 |
|
DBV Technologies
|
6.97 |
|
0.77 |
12.42% |
793.59% |
2025-03-31 |
|
Gilead Sciences
|
112.18 |
|
0.34 |
0.30% |
53.92% |
2025-03-31 |
|
GlaxoSmithKline
|
1,462.00 |
|
-26.50 |
-1.78% |
-12.09% |
2025-03-31 |
|
Glaxosmithkline
|
38.80 |
|
0.06 |
0.14% |
-8.55% |
2025-03-31 |
|
Incyte
|
60.55 |
|
-0.05 |
-0.08% |
6.90% |
2025-03-31 |
|
Ionis Pharmaceuticals
|
30.17 |
|
-0.98 |
-3.15% |
-31.34% |
2025-03-31 |
|
Intra Cellular Therapies
|
131.92 |
|
0.11 |
0.08% |
93.23% |
2025-03-31 |
|
Neurocrine Biosciences
|
110.66 |
|
-2.50 |
-2.21% |
-21.73% |
2025-03-31 |
|
PTC Therapeutics
|
49.89 |
|
-4.35 |
-8.02% |
74.50% |
2025-03-31 |
|
Ultragenyx Pharmaceutical
|
36.46 |
|
-1.36 |
-3.60% |
-22.38% |
2025-03-31 |
|
Regeneron Pharmaceuticals
|
635.08 |
|
-2.64 |
-0.41% |
-34.48% |
2025-03-31 |
|
Roche Holding
|
290.50 |
|
-6.20 |
-2.09% |
27.92% |
2025-03-31 |
|
Sarepta Therapeutics
|
65.09 |
|
-5.33 |
-7.56% |
-49.31% |
2025-03-31 |
|
Vertex Pharmaceuticals
|
484.93 |
|
-7.42 |
-1.51% |
15.33% |
2025-03-31 |